Protein aggregation, misfolding and consequential human neurodegenerative diseases

被引:42
|
作者
Sami, Neha [1 ]
Rahman, Safikur [2 ]
Kumar, Vijay [1 ]
Zaidi, Sobia [1 ]
Islam, Asimul [1 ]
Ali, Sher [1 ]
Ahmad, Faizan [1 ]
Hassan, Md. Imtaiyaz [1 ]
机构
[1] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi, India
[2] Yeungnam Univ, Dept Med Biotechnol, Gyongsan, South Korea
关键词
Protein misfolding; aggregation; amyloids; pathomechanisms; amyotrophic lateral sclerosis; stem cell; AMYOTROPHIC-LATERAL-SCLEROSIS; LOSS-OF-FUNCTION; FRONTOTEMPORAL LOBAR DEGENERATION; STEM-CELL TRANSPLANTATION; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; ALPHA-SYNUCLEIN; GENE-THERAPY; CHEMICAL CHAPERONES; AMYLOID FIBRILS;
D O I
10.1080/00207454.2017.1286339
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Proteins are major components of the biological functions in a cell. Biology demands that a protein must fold into its stable three-dimensional structure to become functional. In an unfavorable cellular environment, protein may get misfolded resulting in its aggregation. These conformational disorders are directly related to the tissue damage resulting in cellular dysfunction giving rise to different diseases. This way, several neurodegenerative diseases such as Alzheimer, Parkinson Huntington diseases and amyotrophic lateral sclerosis are caused. Misfolding of the protein is prevented by innate molecular chaperones of different classes. It is envisaged that work on this line is likely to translate the knowledge into the development of possible strategies for early diagnosis and efficient management of such related human diseases. The present review deals with the human neurodegenerative diseases caused due to the protein misfolding highlighting pathomechanisms and therapeutic intervention.
引用
收藏
页码:1047 / 1057
页数:11
相关论文
共 50 条
  • [41] Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases
    Takeuchi, Toshihide
    Nagai, Yoshitaka
    BRAIN SCIENCES, 2017, 7 (10):
  • [42] Protein misfolding and aggregation: Mechanism, factors and detection
    Chaturvedi, Sumit Kumar
    Siddiqi, Mohammad Khursheed
    Alam, Parvez
    Khan, Rizwan Hasan
    PROCESS BIOCHEMISTRY, 2016, 51 (09) : 1183 - 1192
  • [43] Protein Aggregation and Phase Separation in TDP-43 Associated Neurodegenerative Diseases
    Shi Li-Jun
    Xu An-Qi
    Zhu Li
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2022, 49 (01) : 8 - 22
  • [44] Neuroprotection by Mucuna pruriens in Neurodegenerative Diseases
    Zahra, Walia
    Birla, Hareram
    Singh, Saumitra Sen
    Rathore, Aaina Singh
    Dilnashin, Hagera
    Singh, Richa
    Keshri, Priyanka Kumari
    Gautam, Priyanka
    Singh, Surya Pratap
    NEUROCHEMICAL RESEARCH, 2022, 47 (07) : 1816 - 1829
  • [45] Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases
    Sonninen, Tuuli-Maria
    Goldsteins, Gundars
    Laham-Karam, Nihay
    Koistinaho, Jari
    Lehtonen, Sarka
    CELLS, 2020, 9 (10) : 1 - 23
  • [46] Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases
    Goncalves, Priscila Baltazar
    Sodero, Ana Carolina Renno
    Cordeiro, Yraima
    BIOMOLECULES, 2021, 11 (05)
  • [47] Pathophysiological aspects of human neurodegenerative diseases
    Hortnagl, H
    Hellweg, R
    WIENER KLINISCHE WOCHENSCHRIFT, 1997, 109 (16) : 623 - 635
  • [48] Polyphenolic compounds for treating neurodegenerative disorders involving protein misfolding
    Ho, Lap
    Pasinetti, Giulio Maria
    EXPERT REVIEW OF PROTEOMICS, 2010, 7 (04) : 579 - 589
  • [49] Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases
    Villar-Pique, Anna
    Schmitz, Matthias
    Candelise, Niccolo
    Ventura, Salvador
    Llorens, Franc
    Zerr, Inga
    MOLECULAR NEUROBIOLOGY, 2018, 55 (09) : 7588 - 7605
  • [50] Congo red and protein aggregation in neurodegenerative diseases
    Frid, Petrea
    Anisimov, Sergey V.
    Popovic, Natalija
    BRAIN RESEARCH REVIEWS, 2007, 53 (01) : 135 - 160